Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Pediatr Diabetes. 2016 Feb 4;18(2):95–102. doi: 10.1111/pedi.12359

Fig. 1.

Fig. 1

Shown is the number of assays for the three matrix metalloproteinases (MMPs) that were performed in the diabetic ketoacidosis (DKA) and diabetes control groups based on the volume of blood available. In the DKA group, the number of participants with only a time 1 sample (intravenous access discontinued prior to second sample) vs. both time 1 and time 2 samples is shown.